Literature DB >> 11344092

Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.

G S Robinson1, M Ju, S C Shih, X Xu, G McMahon, R B Caldwell, L E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11344092     DOI： 10.1096/fj.00-0598fje

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  50 in total

Review 1.  Adenosine receptors and caffeine in retinopathy of prematurity.

Authors:  Jiang-Fan Chen; Shuya Zhang; Rong Zhou; Zhenlang Lin; Xiaohong Cai; Jing Lin; Yuqing Huo; Xiaoling Liu
Journal:  Mol Aspects Med       Date:  2017-01-11

2.  Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

Authors:  Swaantje Peters; Sylvie Julien; Peter Heiduschka; Salvatore Grisanti; Focke Ziemssen; Martin Adler; Ulrich Schraermeyer; Karl-Ulrich Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

Review 3.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.

Authors:  Puneet Kumar; Qiang Shen; Christopher D Pivetti; Eugene S Lee; Mack H Wu; Sarah Y Yuan
Journal:  Expert Rev Mol Med       Date:  2009-06-30       Impact factor: 5.600

Review 4.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

5.  Targeted deletion of Vegfa in adult mice induces vision loss.

Authors:  Toshihide Kurihara; Peter D Westenskow; Stephen Bravo; Edith Aguilar; Martin Friedlander
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 6.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword.

Authors:  Susan D Croll; Jeffrey H Goodman; Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

7.  Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Lois E H Smith
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Jan-Rung Mo; Joshua J Ney; Lois E H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-03       Impact factor: 11.205

9.  Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity.

Authors:  Beatrix Feigl; Amanda Greaves; Brian Brown
Journal:  Clin Ophthalmol       Date:  2007-06

10.  Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

Authors:  Luca Filippi; Giacomo Cavallaro; Patrizio Fiorini; Marta Daniotti; Valentina Benedetti; Gloria Cristofori; Gabriella Araimo; Luca Ramenghi; Agostino La Torre; Pina Fortunato; Liliana Pollazzi; Giancarlo la Marca; Sabrina Malvagia; Paola Bagnoli; Chiara Ristori; Massimo Dal Monte; Anna Rita Bilia; Benedetta Isacchi; Sandra Furlanetto; Francesca Tinelli; Giovanni Cioni; Gianpaolo Donzelli; Silvia Osnaghi; Fabio Mosca
Journal:  BMC Pediatr       Date:  2010-11-18       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.